Episode Details

Clinicians, researchers, government and industry partners have come together in a new arrangement to trial a blood test that uses biomarkers for Alzheimer's disease, in the hope it will aid diagnosis.

A new vaccine developed to treat the latest outbreak of ebolavirus is already being tested on humans. But the organisation behind it has also invested in three other vaccines, in case the trials aren't successful. 

Less than one third of general practices provide medical abortion in Australia, with access and support influenced by geographic location and socio-economic status.

References

• Test that could identify signs of Alzheimer's disease 20 years earlier greenlit for trials
• Coalition for Epidemic Preparedness Innovation
• Longitudinal trends and characteristics of medication abortion provision in Australian general practice: a national open-cohort study using Medicine Insight, 2014 to 2021
• Saliva test for endometriosis lacks real-world evidence, Australian experts say
• Vitamin K Prophylaxis in Newborns and Bleeding in Infancy
• Blood tests and ultrasounds: Korea is becoming one of the world's global healthcare hubs